Hepatocellular carcinoma: Which Medications Are Safest? (336 Drugs Compared)
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
336 medications are used for Hepatocellular carcinoma, with 26,911 combined adverse event reports. The most reported drugs for Hepatocellular carcinoma are ATEZOLIZUMAB and BEVACIZUMAB.
26,911
Total Reports
336
Drugs Used
All Medications for Hepatocellular carcinoma Ranked by Safety Reports
| Drug | Brand | Reports | Deaths (all) | Hosp. (all) | Death Rate |
|---|---|---|---|---|---|
| ATEZOLIZUMAB | Tecentriq Hybreza | 8,443 | 8,520 | 15,094 | 25.3% |
| BEVACIZUMAB | JOBEVNE | 7,773 | 17,498 | 23,114 | 22.4% |
| LENVATINIB | Lenvima | 5,384 | 4,449 | 19,975 | 13.2% |
| SORAFENIB | sorafenib | 4,986 | 2,489 | 3,547 | 22.8% |
| CABOZANTINIB S-MALATE | CABOMETYX | 2,670 | 4,203 | 6,193 | 10.7% |
| DURVALUMAB | IMFINZI | 1,255 | 5,088 | 5,968 | 29.7% |
| NIVOLUMAB | OPDIVO | 1,142 | 23,086 | 36,530 | 26.3% |
| REGORAFENIB | Stivarga | 1,050 | 1,869 | 3,363 | 19.8% |
| TREMELIMUMAB\TREMELIMUMAB-ACTL | - | 589 | 328 | 428 | 28.0% |
| PEMBROLIZUMAB | KEYTRUDA | 518 | 15,543 | 35,472 | 18.6% |
| TREMELIMUMAB | IMJUDO | 487 | 594 | 1,510 | 24.9% |
| CABOZANTINIB | - | 437 | 767 | 2,771 | 20.0% |
| DOXORUBICIN | Doxorubicin Hydrochloride | 390 | 15,653 | 28,630 | 18.9% |
| OXALIPLATIN | Oxaliplatin | 288 | 6,501 | 21,980 | 11.5% |
| IPILIMUMAB | YERVOY | 241 | 8,043 | 17,031 | 22.0% |
| FLUOROURACIL | FLUOROURACIL | 235 | 6,997 | 20,941 | 13.2% |
| EPIRUBICIN | Ellence | 168 | 2,212 | 5,603 | 13.6% |
| RAMUCIRUMAB | CYRAMZA | 156 | 1,444 | 2,066 | 27.0% |
| CISPLATIN | CISplatin | 144 | 8,387 | 17,469 | 17.7% |
| NEXAVAR | - | 141 | 99 | 131 | 27.1% |